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Abstract
Background: Medicinal plants are becoming more popular in the treatment of various diseases because of the
adverse effects of the current therapy, especially antioxidant plant components such as phenols and flavonoids
have a protective role against oxidative stress-induced degenerative diseases like diabetes. Thus, the purpose
of this study was to investigate β-cell protection and antidiabetic activities of Crassocephalum crepidioides
(Asteraceae) Benth. S. Moore.
Method: The in-vitro study was conducted by the pancreatic β-cell culture and α-amylase inhibition technique
which includes two methods, namely starch-iodine method and 3,5-dinitrosalicylic acid (DNSA) method. On the
other hand, the in-vivo study was performed by oral glucose tolerance test (OGTT) method and alloxan-induced
diabetes method by using Wistar albino rat. At the end pancreatic specimens were removed and processed for
histopathological study.
Result: The plant extract showed significant (*p < 0.05, **p < 0.01) effect on hyperglycemia as compared to
standard (Gliclazide) in OGTT. The plant extract showed efficient protection activity of pancreatic β-cell from
cell death in INS-1 cell line by significantly reduced (*p < 0.05, **p < 0.01) the levels alloxan-induced apoptosis
and intracellular reactive oxygen species (ROS) accumulation. In addition, the plant extract showed a significant
(*p < 0.05, **p < 0.01) effect on hyperglycemia by increases in percent of β-cells present in each islet (45% – 60%)
compared to the diabetic group.
Conclusion: The result showed that C. crepidioides had β-cell protection and antidiabetic activities in pancreatic
β-cell culture and Wistar albino rat.
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Background
Diabetes mellitus is a metabolic disorder characterized
by high blood sugar (hyperglycemia) due to the distur-
bances of carbohydrate, fat and protein metabolism [1].
It can be classified as type-1 diabetes also known as
insulin-dependent diabetes mellitus (IDDM) and type-2
diabetes also called non-insulin dependent diabetes
mellitus (NIDDM) [2].
Pancreatic α-amylase inhibitors effectively reduced
hyperglycemia through the control of starch breakdown
[3]. Flavonoids or phenolic compounds containing plants
can inhibit α-amylase enzyme lead to reduce blood
glucose level [4]. Alloxan, is a potent diabetogenic agent
that selectively damage pancreatic β-cells and it has been
widely used as diabetes inducer [5]. It has been reported
that alloxan rapidly and selectively accumulates in β-cells
in comparison with non β-cells [6]. The alloxan-induced
pancreatic β-cell damage through the generation of
cytotoxic reactive oxygen species (ROS) [6–9]. The ROS
produced by alloxan is responsible for the breakdown of
DNA strand of pancreatic β–cells [10]. ROS induces
oxidative stress that plays a pathological role in the devel-
opment and progression of diabetic complications [11].
Thus, the identification of potent antidiabetic agents from
natural sources, such as edible plants with minimum side
effects, which will aid in the development of beneficial
dietary guidelines for diabetic patients, is crucial. Recent
studies have demonstrated that medicinal plants can pro-
tect β-cell by reducing alloxan-induced oxidative stress by
scavenging ROS in-vitro and in-vivo, respectively [12–14].
The Crassocephalum crepidioides (C. crepidioides)
Benth. S. Moore (Asteraceae) is an annual, edible herb
also known as redflower ragleaf, that is widespread in
many tropical and subtropical regions. The fleshy muci-
laginous leaves and stems are commonly eaten and differ-
ent parts of the plant have medical uses [15]. Moreover, it
has been reported that C. crepidioides used to treat indi-
gestion, stomach ache, epilepsy, sleeping sickness, swollen
lips and it has also antitumor activity associated with nitric
oxide production [16]. It is a potent antioxidant and
protects against hepatotoxicity [17]. Our previous study
found that, methanol extract of C. crepidioides possesses
significant antioxidant activity as well as promising anti-
hyperlipidemic activity [18]. Despite long traditional use
of C. crepidioides as medicinal herb, no systemic phyto-
chemical and pharmacological works have been carried
out on this potential medicinal plant. Therefore, the aim
of the present study to find out β-cell protection and
antidiabetic effect C. crepidioides.
Methods
Plant material
The aerial parts of C. crepidioides was collected from
Fatickchari, Chittagong in October 2013. The herbarium
sheet was prepared by the expert following the standard
procedure and taxonomic identification was made by
Professor Shaikh Bokhtear Uddin, Department of Botany,
University of Chittagong (CU), Bangladesh. A voucher
specimen (Voucher number: SUS 5396) was deposited in
Department of Botany, CU for preservation.
Preparation of extract
The collected sampls were sliced into smaller pieces and
dried at room temperature under shade and then pow-
dered finely and subjected to extraction. Five hundred
grams of the powder was macerated with about 2500 ml
of 80% methanol for 15 days. The extract was then
filtered and the marc was remacerated twice using the
same volume of solvent to exhaustively extract the plant
material [19]. The methanol was then removed from the
extract by evaporation under reduced pressure using a
rota vapor (BUCHI Rotavapour R-200, Switzerland) at
40 °C. The resulting dry hydroalcoholic extract was
weighed and calculated for percentage yield, which was
23% (w/w). The dried plant extract was reconstituted
with distilled water for oral administration.
Identification of phenolic and flavonoids compound by
chromatographic method
In order to recognize phenolic and flavonoids components
of extract, column chromatography (CC) and thin layer
chromatography (TLC) were used. The extract was sub-
jected to CC with hexane: ethyl acetate in various solvent
ratio. The fractions were collected depending on the
visible changes in the colorful bands running out of the
column. Then the fractions were subjected for TLC profil-
ing. A variety of indicators, including iodine vapour, p-
anisaldehyde-sulphoric acid, chloranil reagent, natural
product reagent, aluminum chloride were used in this
assay. The indicators were sprayed on TLC plate and ob-
served at 254 nm and 365 nm wavelength under UV light.
The Rf values resulted by test samples were 0.88 and 0.93
for extract which were parallel to the Rf values of reference
compounds gallic acid and quercetin.
Determination of α-amylase inhibition by starch-iodine
color assay
Screening of plant material for α–amylase inhibitors was
carried out in a microtitreplate according to based on the
starch-iodine test [20]. The total assay mixture composed
of 200 μL 0.02 M sodium phosphate buffer (pH 6.9 con-
taining 6 mM sodium chloride), 60 μL of porcine pancre-
atic α–amylase (PPA) solution and plant extracts at
concentration from 0 to 200 mg/mL (w/v) was incubated
at 37 °C for 10 min. Then soluble starch 200 μL (1%, w/v)
was added to each reaction well and the mixtures were
then incubated at 37 °C for 15 min. The enzymatic reac-
tion was stopped by the addition of 0.1 M HCl (120 μL)
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followed by the addition of 600 μL of iodine reagent
(5 mM I2 and 5 mM KI). The color change was noted
and the absorbance was read at 620 nm on a microplate
reader. The control reaction representing 100% enzyme
activity did not contain any plant extract. To eliminate
the absorbance produced by plant extract, appropriate
extract controls without the enzyme were also included.
The known PPA inhibitor, acarbose, was used as positive
control at a concentration range of 0–25 mg/mL. A dark-
blue color indicated the presence of starch; a yellow color
indicated the absence of starch while a brownish color in-
dicated partially degraded starch in the reaction mixture.
In the presence of inhibitors of the extracts, the starch
added to the enzyme assay mixture was not degraded and
gave a dark-blue color complex, whereas no color com-
plex was developed in the absence of the inhibitor, indicat-
ing that starch was completely hydrolyzed by α–amylase.
Determination of α-amylase inhibition by 3, 5-
dinitrosalicylic acid (DNSA) assay
The inhibition assay was performed using the chromo-
genic 3, 5-dinitrosalicylic acid (DNSA) method [21].
The total assay mixture composed of 500 μL of 0.02 M
sodium phosphate buffer (pH 6.9 containing 6 mM so-
dium chloride), 20 μL of PPA solution and extracts at
concentration from 0 to 200 mg/mL (w/v) were incu-
bated at 37 °C for 10 min. After pre-incubation, 500 μL
of 1% (v/v) starch solution in the above buffer were
added to each tube and incubated at 37 °C for 15 min.
The reaction was terminated with 1.0 mL DNSA
reagent, placed in boiling water bath for 5 min, cooled
to room temperature, diluted and the absorbance mea-
sured at 540 nm. The known PPA inhibitor, acarbose
was used a positive control at a concentration range of
0–25 mg/mL.
The IC50 values were determined from plots of percent
inhibition versus inhibitor concentration and calculated
by linear regression analysis from the mean inhibitory
values. The IC50 values were defined as the concentra-
tion of the extract containing the α-amylase inhibitor
that inhibited 50% of the PPA activity.
The other quantifiers were calculated as follows:
Percentage of inhibition of the α–amylase activity
¼ 1−Abs controlð Þð Þ– 1−Abs sampleð Þð Þ
1−Abs controlð Þ x 100
Cell culture
INS-1, a rat insulinoma cell line, was obtained from the
American type culture collection (ATCC), USA. The
cells were grown in RPMI-1640 medium supplemented
with 10% fetal bovine serum (FBS), 10 mmol/L HEPES,
2 mmol/L L-glutamine, 50 μmol/L β-mercaptoethanol,
1 mmol/L sodium pyruvate, 100 U/mL penicillin, and
100 μg/mL streptomycin at 37 °C in a humidified atmos-
phere containing 95% air and 5% CO2.
Determination of cell viability
Cell viability was determined by crystal violet assay.
Briefly, INS-1 cells were seeded onto 24-well plate
(5 × 104 cells/well), incubated overnight and pretreated
with various concentrations of extracts (0–1000 μg/mL)
for 24 h. Then, the medium was removed and cells were
washed with phosphate buffer solution (PBS). 200 μL of
0.2% crystal violet solution was added to each well and
incubated for 10 min at room temperature. Then wash
with water and add 100 μL 1% SDS to solubilize the
stain solution until color is uniform and no areas of
dense coloration in bottom of wells. The samples were
read at 590 nm in microplate reader (Spectra MAX,
Gemini EM, Molecular Device).
Analysis of the protective effect of the extract on
oxidative stress induced cytotoxicity
Alloxan-induced cell survival was determined by crystal
violet assay. Briefly, INS-1 cells were seeded (5 × 104
cells/well) and cultured in 24-well culture plates. The
cells were then preincubated with or without different
concentrations of extract (25, 50, 100, and 200 μg/mL)
at 37 °C in a humidified atmosphere of 5% CO2/95% air
for 2 h followed by incubation with 200 μM alloxan for
24 h. After that the medium was removed and cells were
washed with PBS and 200 μl of 0.2% crystal violet solu-
tion was added to each well and incubated for 10 min at
room temperature. Then wash with water and add
100 μL 1% SDS to solubilize the stain solution until the
color is uniform and no areas of dense coloration in
bottom of wells. The samples were read at 590 nm in a
microplate reader (Spectra MAX, Gemini EM, Molecu-
lar Device).
Measurement of intracellular reactive oxygen species
(ROS) level
ROS level was measured by using DCFH-DA method.
DCFH-DA is a non-fluorescent compound, and it can be
enzymatically converted to a highly fluorescent com-
pound, DCF, in the presence of ROS [22]. In brief, after
the treatment, INS-1 cells were washed with PBS and
incubated with DCFH-DA at a final concentration of
10 μmol/L for 30 min at 37 °C in darkness. The fluores-
cence intensity was measured in the microplate reader
(Spectra MAX, Gemini EM, Molecular Device) at an
excitation wave length of 485 nm and an emission wave
length of 538 nm after the cells were washed three times
with PBS to remove the extracellular DCFH-DA. The
level of intracellular ROS was showed as a percentage of
non-treated control.
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Apoptosis assay
Hoechst33342 staining distinguishing apoptotic from
normal cells based on nuclear chromatin condensation
and fragmentation was used for the qualitative and quanti-
tative analyses of the apoptotic cells. INS-1 cells were
cultured in 6-well plates for 24 h. After treatment, the
cells were incubated with 5 μg/ml Hoechst 33,342 for
15 min, washed twice with PBS, and then visualized by
inverted fluorescence microscopy (Axioskop 2 plus micro-
scope, Carl Zeiss, Oberkochen, Germany). The apoptotic
nuclei were counted in at least 200 cells from five non
overlapping fields in all treatment, and expressed as a
percentage of the total number of nuclei counted.
Experimental animal
Wistar albino rats of either sex, aged 8–10 weeks, weigh-
ing 120–250 g were used for the experiment. The animals
were originally obtained from International Centre for
Diarrheal Disease Research, Bangladesh (ICDDR, B). They
were kept in clean and dry polypropylene cages with 12 h
light, dark cycle at 25 ± 2 °C and 45–55% relative humidity
in the animal house. The rats were fed with a standard
laboratory diet and water ad libitum. Food was withdrawn
12 h prior to and during the experiment. As these animals
are very sensitive to environmental changes, they are kept
before the test for at least 3–4 days in the environment
where the experiment will take place. The protocol used
in this study was carried out with the guidelines of the
Institutional Animal Ethics Committee (IAEC) and ap-
proval was taken from ethical committee of Faculty of
Veterinary Medicine, Chittagong Veterinary and Animal
Sciences University.
Acute toxicity studies
Extract at the dose range of 100 mg to 2500 mg/kg were
administered orally to different groups of rats, each group
comprised of five rats. Mortality was observed after 72 h.
Acute toxicity was determined according to the method of
Litchfield and Wilcoxon [23].
Oral glucose tolerance test (OGTT)
OGTT is one of the most acceptable methods to evalu-
ate the hypoglycemic activity [24]. Twenty fasted rats
were divided into four groups with each group contain-
ing five rats. Group 1 was kept as control which received
vehicle orally (p.o.), group 2 received gliclazide 10 mg/kg
as standard, and group 3 and 4 received extracts
300 mg/kg and 500 mg/kg, respectively. After 30 min of
extracts and gliclazide administration all groups were or-
ally treated with 3 g/kg of glucose. The blood glucose
level was measured by glucometer using glucose estima-
tion kit at 0, 30, 90 and 120 mins of glucose loading.
Blood samples were collected from the tail vein.
Induction of diabetes in experimental animals
The rats were fasted for 12 h prior to the induction of
diabetes. Alloxan was freshly prepared in 0.2 ml 0.9%
normal saline was administered intraperitoneally (i.p.) at
a single dose of 150 mg/kg. Development of diabetes
was confirmed by measuring the blood glucose concen-
tration at 48 h after the administration of alloxan. Rats
with blood glucose levels of <7 mmol/dL were excluded
from the experiment. Treatment with plant extracts was
started 48 h after alloxan injection [25].
Experimental design
Animals were divided into five groups with each group
receiving solutions as follows:
Group 1:Normal control (Saline 10 mL/kg, p.o.)
Group 2:Alloxan treated control (150 mg/kg, i.p.)
Group 3:Alloxan (150 mg/kg, i.p.) + plant extract
(150 mg/kg, p.o.)
Group 4:Alloxan (150 mg/kg, i.p.) + plant extract
(300 mg/kg, p.o.)
Saline and plant extract (150 and 300 mg/kg) were
administered to diabetic rats for 14 days and the blood
glucose level was measured at 0, 3, 5, 7, 9 and 14th days.
After 14 days of plant extract treatment, the animals were
sacrificed and blood was collected, sera separated by cen-
trifugation at 3 000 g for 10 min. Details of the estimation
of insulin, urea, creatinine and glycosylated haemoglobin
are given in Additional file 1.
Haemetoxylin and eosin staining
After plant extract treatment, pancreas from the normal
control, alloxan control, and plant extracts (150 and
300 mg/kg)-treated rats were quickly removed for histo-
logical studies. Removed pancreatic tissues were washed
in saline, fixed in 10% formalin and fixed10% neutral buff-
ered formalin (NBF) for 48 h and processed with paraffin
embedding. The sections stained in 0.1% Mayer’s haeme-
toxylin, counterstained in 0.5% eosin, mounted and were
observed under microscope.
Statistical data analysis
All the data were expressed as mean ± SD and one way
ANOVA (Analysis of variance) followed by Dunnett’s test
was used for the statistical analysis using SPSS software




Phytochemical assay by chromatographic method showed
that the main components, including phenolic and flavon-
oid compounds were present in the extract (Table 1).
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α-Amylase inhibition activity
In the present study of the in-vitro α-amylase inhibition
activity test, the extract showed significant % inhibition
of α-amylase relative to the standard treatment, acar-
bose in starch-iodine test and DNSA assay, respectively
(Figs. 1 and 2). In starch-iodine test, acarbose showed
highest α-amylase inhibition of 96.24% at a concentra-
tion of 25 mg/mL (Fig. 1a) with an IC50 value
3.11 ± 0.10 mg/mL (Fig. 1c), while the extract showed a
highest α-amylase inhibition of 66.37% at a concentra-
tion of 200 mg/mL (Fig. 1b) with an 126.85 ± 2.10 mg/
mL (Fig. 1c). In DNSA assay, acarbose showed highest
inhibition of 85.63% at a concentration of 25 mg/mL
(Fig. 2a) with an IC50 value 7.52 ± 0.30 mg/mL (Fig. 2c),
while the extract produced a highest inhibition of 57.76%
at a concentration of 200 mg/mL (Fig. 2b) with an IC50
value 144.29 ± 5.10 mg/mL (Fig. 2c).
Effect of extract on INS-1 cell lines
The cytotoxic effect of the extract on rat pancreatic cell
line INS-1 was evaluated by incubating it with various
concentrations of extract (1–1000 μg/mL). The toxicity
results revealed a decrease in percentage of viability at
higher concentrations of the extract and the IC50 value
was found to be 464.38 ± 3.1 μg/mL (Fig. 3).
Protective effect of extract on alloxan induced cytotoxicity
The effect of extract on the viability of INS-1 cells cul-
tured under alloxan-induced toxicity conditions was mea-
sured by crystal violet assay. Pretreatment of INS-1 cells
for 2 h with extract at concentrations of 25–200 μg/mL
significantly protected INS-1 cells from alloxan toxicity.
An increase in cell viability was observed in treated cells
compared to alloxan control in a dose dependent manner
(Fig. 4). The result displayed that extracts (50 μg/mL,
100 μg/mL and 200 μg/mL) possessed the best protective
effects (p < 0.01).
Effect of extract on intracellular ROS activity
As shown in Fig. 5, after exposed to 200 μmol/L alloxan
for 24 h, the intracellular ROS level of the INS-1 cells
markedly increased to 223.36% relative to the control
value (100%, p < 0.01), which suggests that alloxan induce
oxidative stress [26, 27]. When the cells were incubated
with different concentrations of extract (25, 50, 100 and
Table 1 Phytochemical result of extract
Compounds Reagents Standards Results
Phenols P-Anisaldehyde-Sulphoric acid Gallic acid +
Chloranil reagent Gallic acid +
Flavonoids Natural product reagent Quercetin +
Aluminum chloride Quercetin +
Fig. 1 α-amylase inhibition activity of acarbose and C. crepidioides in starch-iodine assay. a Percentage inhibition of acarbose (b) 80% methanol
extract of C. crepidioides and (c) IC50 of treatment groups on α -amylase enzyme in vitro. Values were represented as mean ± SD (n = 3)
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200 μg/mL) in the presence of 200 μmol/L alloxan for
24 h, the intracellular ROS levels significantly decreased
to 218.22%, 189.73%, 184.07% and 130.8% of the control
value (100%, p < 0.01), respectively.
Effect of the extract on alloxan-induced apoptosis in INS-1
cells
INS-1 cells treated with 200 μmol/L for 24 h showed typ-
ical characteristics of apoptosis, including the condensation
of chromatin, the shrinkage of nuclei, alteration of size,
shape and number of nuclei using Hoechst 33,342
staining as shown in (Fig. 6a). The amount of apoptotic
nuclei was markedly increased, and the apoptosis rate
increased to 22.10% relative to the control group
(100%, p < 0.01). However, pretreatment with extract
(200 μg/ml) in the presence of alloxan (200 μmol/L),
the number of apoptotic cells was obviously decreased,
Fig. 2 α-amylase inhibition activity of acarbose and C. crepidioides in DNSA assay. a Percentage inhibition of acarbose (b) 80% methanol extract
of C. crepidioides and (c) IC50 of treatment groups on α -amylase enzyme in vitro. Values were represented as mean ± SD (n = 3)
Fig. 3 Concentration dependent effect of C. crepidioides extract on
INS-1 cell line. Results are expressed as % of cell reduction (= % of
cell death). Values were represented as mean ± SD (n = 4). Toxicity
results for INS-1 cell line incubated with different concentrations
of extract
Fig. 4 Protective effect of C. crepidioides extract on alloxan induced
cell cytotoxicity in INS-1 cells. Values were represented as mean ± SD
(n = 4). ##p < 0.01 as compared with the control group; **p < 0.01
as compared with the alloxan control group. Toxicity results of INS-1
cell line induced with 200 μM of alloxan and preincubated with
different concentrations of extract
Bahar et al. BMC Complementary and Alternative Medicine  (2017) 17:179 Page 6 of 12
and the apoptosis rate reduced to 14.81% relative to the
control group (100%, p < 0.01) (Fig. 6b).
Acute toxicity
The plant extract did not show any sign of acute toxicity
up to a dose of 2500 mg/kg of body weight. The behavior
of the animals was clearly observed for the first 8 h, then
at an interval of every 8 h during next 72 h. The extract
did not produce a significant change in animal behavior or
mortality.
Effect on OGTT
It was observed that the plant extracts showed a signifi-
cant effect on hyperglycemia as compared to standard
treatment, gliclazide (Fig. 7). In the glucose control
rats, the blood glucose level was increased after 30 min
and remained high over the next 120 min. Plant ex-
tracts (300 mg/kg and 500 mg/kg) significantly reduced
(p < 0.05) the blood glucose level at 30 min and remain
low over the next 120 min when compared with the
glucose control.
Effect on alloxan-induced diabetes
It was observed that both doses (150 mg/kg and 300 mg/
kg) of the extract showed successful hypoglycemic activity
(Fig. 8). In the diabetic control rats, the blood glucose level
was increased and remained high over the 14th days. Plant
extracts significantly reduced (p < 0.05) the blood glucose
level when compared with the diabetic control.
Morphological studies
In histopathological examination, rat pancreatic tissue of
the normal group showed regular exocrine tissue with
interspersed islets of langerhans. No cellular abnormality
Fig. 5 Protective Effect of C. crepidioides extract on alloxan-induced
ROS in INS-1 cells. DCF fluorescence reflects ROS level. Values were
represented as mean ± SD from three independent experiments.
##p < 0.01 as compared with the control group; *p < 0.05 and
**p < 0.01 as compared with the alloxan control group. Intracellular
ROS activity results for INS-1 cell line induced with 200 μM of alloxan
and pre incubated with different concentrations of extract
a
b
Fig. 6 Protective effects of C. crepidioides extract on the cell survival in alloxan-treated INS-1 cells by Hoechst 33,342 staining method. a Representative
images by Hoechst 33,342 staining, arrowheads in the pictures indicate the nuclei of the apoptotic cells (Hoechst-positive cells). b The apoptosis rate
was determined by calculating the percentage of Hoechst positive cells over the total number of cells. Values were represented as mean ± SD from
three independent experiments. ##p < 0.01 as compared with the control group; **p < 0.01 as compared with the alloxan control group. Apoptosis
activity results for INS-1 cell line induced with 200 μM of alloxan and pre incubated with different concentrations of extract
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or inflammatory infiltration was seen (Fig. 9a). The rat
pancreatic tissue of the diabetic control group revealed
regular exocrine pancreas with a reduced number of is-
lets of langerhans. As a whole, each islet contained a re-
duced number of cells. Furthermore, few pyknotic cells
along with mild infiltration of lymphocytes were ob-
served within the islets (Fig. 9b). Rat pancreatic tissues
of the plant extract 150 mg/kg and 300 mg/kg groups
showed regular exocrine pancreas with moderately in-
creased number and size of islets of langerhans as well
as increased number of cells per islets with a distinct
margin between exocrine and endocrine tissue (Fig. 9c, d).
In the plant extract-treated group, morphometric results
showed a significant increase in the number of the is-
lets/mm2 (Table 2) and the number of β-cells in islet
compared to the diabetic group (Table 3). There was no
significant difference in the number of islets/mm2com-
pared to the normal group. There was a significant de-
crease in the percent of β-cells (25% – 30%) in the
diabetic group, while there was a significant increase in
the plant extract-treated group (45% – 60%) compared
to the diabetic groups (Fig. 9e).
Discussion
The blood glucose level has been increased by the α-
amylase and α-glucosidase enzyme which break carbo-
hydrate to simple absorbable monosaccharides [28].
The α-amylase and α–glucosidase inhibitors have been
useful as oral hypoglycemic drugs for the control of
hyperglycemia especially in patients with type II dia-
betes mellitus [29]. Inhibition of α-amylase delays
carbohydrate digestion and prolong overall digestion
time lead to reduce rate of glucose absorption and ul-
timately reducing the blood glucose level [30]. In our
study, the plant extract showed significant % inhibition
of α-amylase as compared to the standard anti-diabetic
drug, acarbose, in both starch-iodine test and DNSA
assay that could be attributed to the presence of phen-
olic and flavonoids components (Table 1) because
polyphenols are capable of inhibiting carbohydrate
hydrolyzing enzymes due to their ability to bind with
proteins [31, 32].
Our results in this study showed pretreatment of INS-
1 cells cultured under alloxan-induced cytotoxicity, with
extract significantly increased survival and decreased
rate of cell death. Treatment of INS-1 cells with extract
also reduced ROS intracellular formation and decreased
cell apoptosis that indicate the pancreatic β-cell protect-
ive effect of extract on the INS-1 cell line [33–35].
Furthermore, the study revealed that the plant extract
showed a significant effect on hyperglycemia as com-
pared to standard treatment, gliclazide, in OGTT.
OGTT was used to identify the altered carbohydrate
metabolism during post glucose administration. The
ability of extract to lower the blood glucose level in oral
glucose tolerance test suggests that rats treated with
plant extract had better glucose utilization capacity
[36]. It is also well established that sulfonylureas (e.g.
gliclazide) cause hypoglycemia by stimulating insulin
release from pancreatic β-cells [37]. Our result showed
that the extract groups of diabetic rats significantly
increased (p < 0.05 or p < 0.01) the serum insulin
(Additional file 1: Table S1). The comparable effect of
the extract with gliclazide suggests the possibility of a
similar mode of action.
Additionally, our results demonstrated that the plant
extracts showed significant effect on hyperglycemia as
compared to alloxan control rats. The blood glucose
lowering effect of plant extract could be attributed to
Fig. 7 Effect of C. crepidioides extract on OGTT. Values were
represented as mean ± SD (n = 6). *p < 0.05 and **p < 0.01 as
compared with the glucose control group
Fig. 8 Effect of C. crepidioides extract on alloxan-induced diabetic
rats. Values were represented as mean ± SD (n = 6). *p < 0.05 and
**p < 0.01 as compared with the alloxan control group
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the presence of flavonoids and phenolic compounds
(Table 1) that have been associated with hypoglycemic
activity [38, 39].
Histological findings of the pancreatic tissue using
haematoxylin of the control group showed bluish-
stained β-cells filling the interior of the islet, while pink-
stained α-cells were arranged in mainly clusters located
at the periphery of the islets and also between β-cells.
Alloxan administration exhibited degenerative changes
at the center of islets of langerhans and also decreased
number of the bluish-stained β-cells, while the pink-
stained α-cells remained present at the periphery of the
islet. The alloxan caused significant morphological
changes in diabetic rats with severe pancreatic β-cells
destruction, such as decreasing the islets cell numbers,
cell damage, and cell death as compared to the control
group [40, 41]. The cytotoxic action of alloxan is medi-
ated by ROS, with a simultaneous massive increase in
cytosolic calcium concentration leading to rapid de-






Fig. 9 Histopathological examination under microscopy: (a) Normal cellular population in the islets of langerhans in pancreas of vehicle-treated
rats. b Extensive damage to the islets of langerhans and reduced dimensions of islets in diabetic control rats. (c, d) The partial restoration of
normal cellular population and enlarged size of β-cells were shown by the extracts (150 mg/kg and 300 mg/kg), respectively. e The β-cell
regeneration rate was determined by calculating the percentage of H & E positive cells over the total number of cells. Values were represented
as mean ± SD. ##p < 0.01 as compared with the control group; *p < 0.05 and **p < 0.01 as compared with the alloxan control group
Table 2 The number of islets/mm2 in the control and treatment
groups
Groups Number of islets/mm2
Normal control 5.2 ± 0.62
Alloxan control 1.4## ± 0.93
Alloxan + Extract (150 mg/kg) 2.9* ± 0.44
Alloxan + Extract (300 mg/kg) 3.9** ± 0.31
Values were represented as mean ± SD. ##p < 0.01 as compared with the
control group; *p < 0.05 and **p < 0.01 as compared with the alloxan
control group
Table 3 The number of β cells per islet in the control and
treatment groups
Groups Number of β cells/ islet
Normal control 94.60 ± 6.02
Alloxan control 28.92## ± 2.13
Alloxan + Extract (150 mg/kg) 42.2* ± 3.31
Alloxan + Extract (300 mg/kg) 56.4** ± 4.01
Values were represented as mean ± SD. ##p < 0.01 as compared with the
control group;
*p < 0.05 and **p < 0.01 as compared with the alloxan control group
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a significant increase in the number of the islets/mm2
and the number of β-cells in islet compared to dia-
betic group. The plant extract may act on islet func-
tions (Table 2) lead to increasing the number of
pancreatic islets (Table 3) pancreatic β-cells from oxi-
dative damage through regulating ROS production
(Fig. 5) and apoptotic rate (Fig. 6) [44, 45]. In sum-
mary, the results of this study showed the pancreatic
β-cell protective properties of the extract through re-
ducing the ROS production and decreasing the cell
apoptosis (Fig. 10) that might be due to presence of
flavonoids, polyphenolic compounds (Table 1) [46].
Therefore, this medicinal plant as a Complementary
Medicine strategy may be used in metabolic diabetic
diseases; however, further study is needed.
Conclusions
This study demonstrates that the extract possesses a sig-
nificant anti-diabetic activity at different dose levels in
both in-vitro and animal models. Hence, the study of in-
vitro and in-vivo pharmacological and phytochemical
evaluation of this plant forms a primary platform for fu-
ture studies. The anti-apoptotic signaling mechanism of
active compounds from this promissory extract should
be further investigated as a natural remedy for diabetes
treatment.
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